195 related articles for article (PubMed ID: 11912381)
1. Comparison of contrast enhanced color Doppler targeted biopsy with conventional systematic biopsy: impact on prostate cancer detection.
Frauscher F; Klauser A; Volgger H; Halpern EJ; Pallwein L; Steiner H; Schuster A; Horninger W; Rogatsch H; Bartsch G
J Urol; 2002 Apr; 167(4):1648-52. PubMed ID: 11912381
[TBL] [Abstract][Full Text] [Related]
2. Comparison of contrast enhanced color Doppler targeted biopsy to conventional systematic biopsy: impact on Gleason score.
Mitterberger M; Pinggera GM; Horninger W; Bartsch G; Strasser H; Schäfer G; Brunner A; Halpern EJ; Gradl J; Pallwein L; Frauscher F
J Urol; 2007 Aug; 178(2):464-8; discussion 468. PubMed ID: 17561137
[TBL] [Abstract][Full Text] [Related]
3. A prospective randomized trial comparing contrast-enhanced targeted versus systematic ultrasound guided biopsies: impact on prostate cancer detection.
Mitterberger M; Horninger W; Pelzer A; Strasser H; Bartsch G; Moser P; Halpern EJ; Gradl J; Aigner F; Pallwein L; Frauscher F
Prostate; 2007 Oct; 67(14):1537-42. PubMed ID: 17705242
[TBL] [Abstract][Full Text] [Related]
4. Comparison of sonoelastography guided biopsy with systematic biopsy: impact on prostate cancer detection.
Pallwein L; Mitterberger M; Struve P; Horninger W; Aigner F; Bartsch G; Gradl J; Schurich M; Pedross F; Frauscher F
Eur Radiol; 2007 Sep; 17(9):2278-85. PubMed ID: 17342485
[TBL] [Abstract][Full Text] [Related]
5. Prostate cancer detection in men with prostate specific antigen 4 to 10 ng/ml using a combined approach of contrast enhanced color Doppler targeted and systematic biopsy.
Pelzer A; Bektic J; Berger AP; Pallwein L; Halpern EJ; Horninger W; Bartsch G; Frauscher F
J Urol; 2005 Jun; 173(6):1926-9. PubMed ID: 15879783
[TBL] [Abstract][Full Text] [Related]
6. Targeted biopsy of the prostate: the impact of color Doppler imaging and elastography on prostate cancer detection and Gleason score.
Nelson ED; Slotoroff CB; Gomella LG; Halpern EJ
Urology; 2007 Dec; 70(6):1136-40. PubMed ID: 18158034
[TBL] [Abstract][Full Text] [Related]
7. Contrast-enhanced colour Doppler-targeted vs a 10-core systematic repeat biopsy strategy in patients with previous high-grade prostatic intraepithelial neoplasia.
Mitterberger M; Horninger W; Aigner F; Pinggera GM; Rehder P; Steiner E; Wiunig C; Reissigl A; Frauscher F
BJU Int; 2010 Jun; 105(12):1660-2. PubMed ID: 19863528
[TBL] [Abstract][Full Text] [Related]
8. Colour Doppler and microbubble contrast agent ultrasonography do not improve cancer detection rate in transrectal systematic prostate biopsy sampling.
Taverna G; Morandi G; Seveso M; Giusti G; Benetti A; Colombo P; Minuti F; Grizzi F; Graziotti P
BJU Int; 2011 Dec; 108(11):1723-7. PubMed ID: 21756276
[TBL] [Abstract][Full Text] [Related]
9. The influence of prostate volume on prostate cancer detection using a combined approach of contrast-enhanced ultrasonography-targeted and systematic grey-scale biopsy.
Colleselli D; Bektic J; Schaefer G; Frauscher F; Mitterberger M; Brunner A; Schwentner C; Bartsch G; Horninger W; Pelzer AE
BJU Int; 2007 Dec; 100(6):1264-7. PubMed ID: 17850369
[TBL] [Abstract][Full Text] [Related]
10. Optimal combinations for detection of prostate cancer: systematic sextant and laterally directed biopsies versus systematic sextant and color Doppler-targeted biopsies.
Kravchick S; Cytron S; Peled R; London D; Sibi Y; Ben-Dor D
Urology; 2004 Feb; 63(2):301-5. PubMed ID: 14972476
[TBL] [Abstract][Full Text] [Related]
11. Results of vardenafil mediated power Doppler ultrasound, contrast enhanced ultrasound and systematic random biopsies to detect prostate cancer.
Morelli G; Pagni R; Mariani C; Minervini R; Morelli A; Gori F; Ferdeghini EM; Paterni M; Mauro E; Guidi E; Armillotta N; Canale D; Vitti P; Caramella D; Minervini A
J Urol; 2011 Jun; 185(6):2126-31. PubMed ID: 21496853
[TBL] [Abstract][Full Text] [Related]
12. Contrast-enhanced ultrasonography using cadence-contrast pulse sequencing technology for targeted biopsy of the prostate.
Aigner F; Pallwein L; Mitterberger M; Pinggera GM; Mikuz G; Horninger W; Frauscher F
BJU Int; 2009 Feb; 103(4):458-63. PubMed ID: 19021610
[TBL] [Abstract][Full Text] [Related]
13. Dutasteride prior to contrast-enhanced colour Doppler ultrasound prostate biopsy increases prostate cancer detection.
Mitterberger M; Pinggera G; Horninger W; Strasser H; Halpern E; Pallwein L; Gradl J; Bartsch G; Frauscher F
Eur Urol; 2008 Jan; 53(1):112-7. PubMed ID: 17321668
[TBL] [Abstract][Full Text] [Related]
14. Additional Targeted Biopsy in Clinically Suspected Prostate Cancer: Prospective Randomized Comparison between Contrast-Enhanced Ultrasound and Sonoelastography Guidance.
Koh J; Jung DC; Oh YT; Yoo MG; Noh S; Han KH; Rha KH; Choi YD; Hong SJ
Ultrasound Med Biol; 2015 Nov; 41(11):2836-41. PubMed ID: 26298036
[TBL] [Abstract][Full Text] [Related]
15. Contrast-enhanced ultrasonography with contrast-tuned imaging technology for the detection of prostate cancer: comparison with conventional ultrasonography.
Xie SW; Li HL; Du J; Xia JG; Guo YF; Xin M; Li FH
BJU Int; 2012 Jun; 109(11):1620-6. PubMed ID: 21939490
[TBL] [Abstract][Full Text] [Related]
16. Predictors of prostate carcinoma: accuracy of gray-scale and color Doppler US and serum markers.
Kuligowska E; Barish MA; Fenlon HM; Blake M
Radiology; 2001 Sep; 220(3):757-64. PubMed ID: 11526279
[TBL] [Abstract][Full Text] [Related]
17. Detection of prostate carcinoma with contrast-enhanced sonography using intermittent harmonic imaging.
Halpern EJ; Ramey JR; Strup SE; Frauscher F; McCue P; Gomella LG
Cancer; 2005 Dec; 104(11):2373-83. PubMed ID: 16240450
[TBL] [Abstract][Full Text] [Related]
18. Are transition zone biopsies still necessary to improve prostate cancer detection? Results from the tyrol screening project.
Pelzer AE; Bektic J; Berger AP; Halpern EJ; Koppelstätter F; Klauser A; Rehder P; Horninger W; Bartsch G; Frauscher F
Eur Urol; 2005 Dec; 48(6):916-21; discussion 921. PubMed ID: 16126324
[TBL] [Abstract][Full Text] [Related]
19. Value of real-time elastography targeted biopsy for prostate cancer detection in men with prostate specific antigen 1.25 ng/ml or greater and 4.00 ng/ml or less.
Aigner F; Pallwein L; Junker D; Schäfer G; Mikuz G; Pedross F; Mitterberger MJ; Jaschke W; Halpern EJ; Frauscher F
J Urol; 2010 Sep; 184(3):913-7. PubMed ID: 20643432
[TBL] [Abstract][Full Text] [Related]
20. Comparative efficiency of contrast-enhanced colour Doppler ultrasound targeted versus systematic biopsy for prostate cancer detection.
Mitterberger MJ; Aigner F; Horninger W; Ulmer H; Cavuto S; Halpern EJ; Frauscher F
Eur Radiol; 2010 Dec; 20(12):2791-6. PubMed ID: 20571801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
